Source: Annual Congress 2003 - Issues surrounding drug delivery



Rating:

Share or cite this content

Citations should be made in the following way:
C. M. Kähler, J. Wechselberger, J. Hamacher, W. Hilbe, G. Stockhammer, C. J. Wiedermann, E. Gunsilius (Innsbruck, Austria; Konstanz, Germany). The trojan horse: a new gene therapeutic concept in pulmonology - endothelial progenitor cells as vector. Eur Respir J 2003; 22: Suppl. 45, 2996

Member's Comments

No comment yet.

Related content which might interest you: siRNA in human epithelial cells and macrophages Source: Annual Congress 2005 - Selective gene knockout - the use of small interference RNA Year: 2005 Embryonic stem cells as source for endothelial cells for cell-based therapies Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension Year: 2010 Effects of adenoviral gene transfer of mutated IκBα, a novel inhibitor of NF-κB, on human monocyte-derived dendritic cells Source: Eur Respir J 2006; 28: Suppl. 50, 759s Year: 2006 Stem cells, lung pathogenesis and therapeutic potential Source: Annual Congress 2005 - Scientific year in review Year: 2005 Isolation & characterisation of resident fetal human lung progenitor cells Source: Annual Congress 2009 - Experimental approaches in animals and modelling in humans Year: 2009 Comparative lentiviral versus adenoviral gene transfer of GM-CSF to bone marrow-derived versus pulmonary macrophages of mice Source: International Congress 2015 – Management of TB: a patient focus Year: 2015 Gene therapeutic approaches: from stem cell therapy to gene delivery Source: Annual Congress 2006 - Pulmonary hypertension at the crossroads of science and clinical medicine Year: 2006 Lung stem cells: therapeutic prospects Source: Lung Science Conference 2005 - Evidence-based medicine for respiratory disease with special emphasis on inflammatory processes Year: 2005 Endothelin and endothelial progenitor cells: a novel link in vasculogenesis Source: Eur Respir J 2005; 26: Suppl. 49, 225s Year: 2005 Immunotherapeutic strategy with mesenchymal stem cells modulating inflammation in an experimental model of COPD. Source: Virtual Congress 2020 – New insight into the immunology of asthma and COPD Year: 2020 Therapeutic potential of mesenchymal stem cells modified to secrete anti-inflammatory protein sST2 in a model of occupational asthma Source: Annual Congress 2012 - Occupational asthma Year: 2012 Generation from peripheral blood CD34+ progenitors of a novel NK-2 subset that produces IL-21 and renders tolerogenic myeloid dendritic cells. A paradox for allergy treatment? Source: Eur Respir J 2007; 30: Suppl. 51, 135s Year: 2007 Transcriptional characterisation of human lung cells identifies novel mesenchymal lineage markers Source: Eur Respir J, 55 (1) 1900746; 10.1183/13993003.00746-2019 Year: 2020 Identification of a candidate progenitor cell for dendritic cells and other antigen-presenting cells within in the mouse respiratory tract Source: Annual Congress 2006 - Immunology of the airways Year: 2006 Modelling human lung development and disease using pluripotent stem cells Source: International Congress 2015 – Regenerative medicine of the lung: opportunities and threats Year: 2015 In search of ckit+ stem cells in lung tissue Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema Year: 2015